Elizabeth Kukielka, PharmD

A daily, 6-month ATT regimen in HIV-positive patients with TB receiving concomitant ART proved superior to an intermittent regimen in terms of efficacy and prevention of ARR.

The outcomes from the meta-analysis provide strong evidence for the elevated risk of mortality among lung cancer patients with HIV infection.

No linear association was found between CD4 cell count and blood pressure after adjusting for important confounders in patients with HIV.

This is the first study to present nationally representative estimates of HIV testing prevalence and factors associated with HIV testing among sexually active older adults.

A joint effort must be made to include PLWH from these at-risk groups in observational and interventional studies to understand stroke mechanisms and reducing stroke risk in HIV infection.

Results contradicted previous studies that did not account for baseline differences between DAA- and interferon-treated patients.

There were no differences in anxiety and depression scores between perinatally-acquired HIV and HIV-affected participants.

Adherence to generic multi-tablet regimens was high and comparable with adherence to brand multi-tablet regimens and to single tablets.

Offering PrEP at public health-care clinics in a middle-income setting can retain high numbers of participants and achieve high levels of adherence without risk compensation in investigated populations.

Elevated thyroid stimulating hormone was linked to female sex, higher BMI, liver fibrosis, AST, and low albumin.

To date, there has been no assessment of CMV reactivation and CV risk in liver transplant patients.

Results indicate novel activation of CD4+ T-cells among HIV-infected youth who have STIs aside from HSV, contributing to disease progression.

Most of the high-risk HPV types detected were included in the 9v vaccine, impacting clearance rates by decreasing the overall burden of infection in HIV-infected women.

There has been only 1 study into the effect of viral eradication using interferon-based HCV therapy on the development of hepatic steatosis in patients with genotype 3 infection.

Information sources such as healthcare professionals, social support and TV ads remain widely used for self-care.

Spontaneous clearance peaks at 12 months, with 36.1% of patients achieving spontaneous clearance of HCV by that point in time.

Data suggest that some gay and other men who have sex with men are using antiretroviral medications without a prescription.

The research has the potential to add a less expensive adjunctive therapy to improve current HCV regimens.

Combination ART has dramatically improved survival rates among those living with HIV and is a mainstay of HIV prevention.

Patients with hepatitis C and IR can develop a resistance to antiviral therapy, as well as fibrosis, steatosis, hepatocellular carcinoma.

Although recent data suggests that the number of children born infected with HCV is on the rise, the number of reported cases is lower than expected

HCV vaccine candidates have been yielded by the virus genome's high genetic variability, and lacking suitable animal models.